Tharimmune, a company listed in the United States, has filed definitive additional materials with the Securities and Exchange Commission (SEC) as part of its proxy statement process. This filing, known as Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934 and is used to provide shareholders with information necessary for making informed decisions at shareholder meetings. Tharimmune has confirmed that no filing fee is required for this submission. The materials filed are not preliminary proxy statements, confidential materials, definitive proxy statements, or soliciting materials under § 240.14a-12, indicating that this is an additional submission following a definitive proxy statement that has already been filed by the registrant, Tharimmune, Inc.

Tharimmune, a company listed in the United States, has filed definitive additional materials with the Securities and Exchange Commission (SEC) as part of its proxy statement process. This filing, known as Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934 and is used to provide shareholders with information necessary for making informed decisions at shareholder meetings. Tharimmune has confirmed that no filing fee is required for this submission. The materials filed are not preliminary proxy statements, confidential materials, definitive proxy statements, or soliciting materials under § 240.14a-12, indicating that this is an additional submission following a definitive proxy statement that has already been filed by the registrant, Tharimmune, Inc.